Covaxin
Covishield and Covaxin: What we know about India's Covid-19 vaccines
India's Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows.
Covid-19 in Bangladesh: Daily infection rate rises, 8 more die
Eight more Covid-19-related deaths and 585 new cases were reported in Bangladesh in the last 24 hours till Monday morning, showing a substantial rise in its daily infection rate.
India confirms 447 cases of adverse events following COVID-19 vaccination
A total of 447 cases of Adverse Event Following Immunization (AEFIs) after the COVID-19 vaccination have been reported over the past two days, out of whom three required hospitalization, India's health ministry said on Sunday.
India starts shipping COVID-19 vaccine to cities
India has started shipping COVID-19 vaccines to multiple cities, four days ahead of the nationwide inoculation drive.
India OKs AstraZeneca, locally-made COVID-19 vaccines
India authorised two COVID-19 vaccines on Sunday, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country.
Haryana health minister tests Covid-19 positive after vaccine shot
Haryana Health Minister Anil Vij tested Covid-19 positive Saturday, more than 15 days after he was administered a trial dose of Bharat Biotech's Covid-19 vaccine candidate Covaxin.
Bharat Biotech to begin phase-3 trials of Covid vaccine soon
Bharat Biotech is likely to start the phase-3 trial of its coronavirus vaccine in India next month after receiving approval from the drug regulatory authority.